Thanks Ajostu, no problem.
Correct, there were no SAEs as highlighted in the 4D announcement...
No serious adverse events (SAEs) have been reported and no subjects have discontinued treatment due to side effects.
Here's an overview...
http://www.fda.gov/safety/medwatch/howtoreport/ucm053087.htm
Tony
retts syndrome, page-33
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.81 |
Change
0.060(0.44%) |
Mkt cap ! $1.765B | |||
| Open | High | Low | Value | Volume |
| $13.85 | $14.08 | $13.46 | $6.963M | 507.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3724 | $13.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.84 | 2087 | 1 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |